GKB Ophthalmics (BOM:533212) Debt-to-Equity : N/A (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is GKB Ophthalmics Debt-to-Equity?

GKB Ophthalmics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. GKB Ophthalmics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. GKB Ophthalmics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for GKB Ophthalmics's Debt-to-Equity or its related term are showing as below:

BOM:533212' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.15 Med: 0.19 Max: 0.32
Current: 0.18

During the past 13 years, the highest Debt-to-Equity Ratio of GKB Ophthalmics was 0.32. The lowest was 0.15. And the median was 0.19.

BOM:533212's Debt-to-Equity is ranked better than
54.55% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs BOM:533212: 0.18

GKB Ophthalmics Debt-to-Equity Historical Data

The historical data trend for GKB Ophthalmics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GKB Ophthalmics Debt-to-Equity Chart

GKB Ophthalmics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.26

0.19

0.18

GKB Ophthalmics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.18	N/A	0.18	N/A

Competitive Comparison of GKB Ophthalmics's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GKB Ophthalmics's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where GKB Ophthalmics's Debt-to-Equity falls into.

GKB Ophthalmics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

GKB Ophthalmics's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(100.456	+	11.7)	/	626.932
	=	0.18

GKB Ophthalmics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

GKB Ophthalmics (BOM:533212) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

GKB Ophthalmics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of GKB Ophthalmics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GKB Ophthalmics (BOM:533212) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GKB Ophthalmics Ltd (BOM:533212) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526

Website

https://www.gkb.net

GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.

GKB Ophthalmics (BOM:533212) Headlines

No Headlines